Swiss family office anfass Life Technologies and the German investment firm Picus Capital will be cooperating in financing early-stage startups in the future. Both companies take a long-term approach to their investments and are strengthening their activities in Switzerland and Germany through the collaboration.

anfass Life Technologies has assisted 4D Lifetec AG, one of our Medtech/Diagnostics portfolio companies, in placing and successfully closing a CHF 1.9 million Series B financing for the market launch of its liquid biopsy assay 4D Lifetest™ Lung Dx for the early detection of lung cancer in Europe. We congratulate and wish the company ongoing success.

Since 2017 this abc biopply is a part of anfass Life Technologies biotech portfolio. The company now has reported last year’s revenues up more than twice in its strategic core business.

anfass Life Technologies AG, known for its activity as an incubator of innovative ideas and projects, supports with the project Aaregondel an innovative mobility concept for regional public transportation in Solothurn.

We congratulate Borer Chemie AG on the successful organization of this year's Industry Day of the INVESO with around 80 guests from politics and business in Solothurn.

As a logical next step in the company's development, BKW Building Solutions AG has taken over the entire share capital of the company and is now the full owner of alphaTrust.ch ag.

The two life science companies have entered into a collaboration for the co-development of highly effective antibodies without animal testing. For this purpose, Quadira Biosciences AG has been founded as a joint venture.

We are very proud that one of our Swiss portfolio companies is developing so promisingly and is now by signing a collaboration agreement with an U.S.-listed company already being internationally acknowledged.

Our most recent investment is in a new company that provides solutions for accurate and rapid pathogen detection for industrial applications.

Congratulations to this further, very important milestone.

Our employee Jacqueline Felber has successfully finished her CAS degree in Digital Marketing and Transformation.

Since 2014, anfass Life Technologies AG has been supporting a Swiss start-up that aims to establish itself in the early detection of cancer.

Since 2014 anfass Life Technologies AG acts as lead investor for abc biopply ag and is providing management and marketing support. Together with the launch of the company’s new technology platform 3D CoSeedis™ our anfass LT marketing has now launched abc biopply`s new exciting web presence.

Our participaton at the Future Health Conference in Basel has been very valuable to us.

Thank you to our guests for the great evening and admiration for the artist Renu G.

We are pleased to introduce you our new team member.

We honour our Senior Client Partner Giancarlo Rizzoli.

anfass Life Technologies AG looks back on a successful year 2016.

For a Swiss start-up, anfass Life Technologies had to be able to organize a scientific event. For that we summoned internationally renowned researchers to Solothurn.

For the first time in Switzerland, people will be able to admire photos from the photo collection "Fascination Water - the sculptural and graphical art of water" by Steffen Faisst.

On the 29th April 2016, anfass Life Technologies AG threw an Open Office Day to celebrate the purchase of new premises at a new location with friends, partners and neighbours.